Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors

被引:0
作者
Toth, Paul D. [1 ]
Ratigan, Steven C. [2 ]
Powell, Joshua W. [2 ]
Cassel, Sydney R. [3 ]
Yalowich, Jack C. [3 ]
McElroy, Craig A. [2 ]
Lindert, Steffen [1 ]
Bell, Charles E. [4 ]
Mitton-Fry, Mark J. [2 ]
机构
[1] Ohio State Univ, Coll Arts & Sci, Dept Chem & Biochem, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmacol, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Med, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2025年
基金
美国国家卫生研究院;
关键词
gyrase; amide; triazole; crystallography; moleculardynamics; DNA GYRASE; DERIVATIVES; SAR;
D O I
10.1021/acsmedchemlett.5c00060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel bacterial topoisomerase inhibitors (NBTIs) targeting DNA gyrase and topoisomerase IV constitute a new antibacterial class for deadly pathogens such as MRSA. While most NBTIs induce gyrase-mediated single-strand DNA breaks, a subset of amide NBTIs induces both single-strand and double-strand DNA breaks. Here, we report the X-ray crystal structures of two such amide NBTIs, 148 and 185, and demonstrate an unusual binding mode characterized by engagement of both GyrA D83 and R122. The synthesis of two isosteric triazole NBTIs is also described, one of which (342) affords only single-strand DNA breaks, while the other (276) also induces both single- and double-strand DNA breaks. A combination of docking and molecular dynamics simulations is employed to further investigate the potential structural underpinnings of differences in DNA cleavage.
引用
收藏
页码:660 / 667
页数:8
相关论文
共 50 条
  • [21] Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments
    Kolaric, Anja
    Novak, Doroteja
    Weiss, Matjaz
    Hrast, Martina
    Zdovc, Irena
    Anderluh, Marko
    Minovski, Nikola
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (09) : 935 - 945
  • [22] Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors
    Lyons, Amanda
    Kirkham, James
    Blades, Kevin
    Orr, David
    Dauncey, Elizabeth
    Smith, Oliver
    Dick, Emma
    Walker, Rolf
    Matthews, Teresa
    Bunt, Adam
    Finlayson, Jonathan
    Morrison, Ian
    Savage, Victoria J.
    Moyo, Emmanuel
    Butler, Hayley S.
    Newman, Rebecca
    Ooi, Nicola
    Smith, Andrew
    Charrier, Cedric
    Ratcliffe, Andrew J.
    Stokes, Neil R.
    Best, Stuart
    Salisbury, Anne-Marie
    Craighead, Mark
    Cooper, Ian R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 65
  • [23] Synthesis and mechanistic insights of Coumarinyl-Indolinone hybrids as potent inhibitors of Leishmania major
    Batran, Rasha Z.
    Ebaid, Manal S.
    Nasralla, Sherry N.
    Son, Ninh The
    Ha, Nguyen Xuan
    Ibrahim, Hoda Atef Abdelsattar
    Alkabbani, Mahmoud Abdelrahman
    Kasai, Yusuke
    Imagawa, Hiroshi
    Al-Sanea, Mohammad M.
    Ibrahim, Tamer M.
    Elshamy, Abdelsamed I.
    Bekhit, Adnan A.
    Eldehna, Wagdy M.
    Sabt, Ahmed
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 288
  • [24] Opioid receptors: Structural and mechanistic insights into pharmacology and signaling
    Shang, Yi
    Filizola, Marta
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 206 - 213
  • [25] Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
    D'Atanasio, Noemi
    de Joannon, Alessandra Capezzone
    Di Sante, Laura
    Mangano, Giorgina
    Ombrato, Rosella
    Vitiello, Marco
    Bartella, Cristina
    Magaro, Gabriele
    Prati, Federica
    Milanese, Claudio
    Vignaroli, Carla
    Di Giorgio, Francesco Paolo
    Tongiani, Serena
    PLOS ONE, 2020, 15 (02):
  • [26] Advances in structure-based drug design of novel bacterial topoisomerase inhibitors
    Widdowson, Katherine
    Hennessy, Alan
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (11) : 1619 - 1622
  • [27] Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors
    Yu, Xufen
    Zhang, Mingming
    Annamalai, Thirunavukkarasu
    Bansod, Priyanka
    Narula, Gagandeep
    Tse-Dinh, Yuk-Ching
    Sun, Dianqing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 515 - 527
  • [28] Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays
    Sandhaus, Shayna
    Chapagain, Prem P.
    Tse-Dinh, Yuk-Ching
    SCIENTIFIC REPORTS, 2018, 8
  • [29] Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents
    Singh, Sheo B.
    Kaelin, David E.
    Wu, Jin
    Miesel, Lynn
    Tan, Christopher M.
    Meinke, Peter T.
    Olsen, David
    Lagrutta, Armando
    Bradley, Prudence
    Lu, Jun
    Patel, Sangita
    Rickert, Keith W.
    Smith, Robert F.
    Soisson, Stephen
    Wei, Changqing
    Fukuda, Hideyuki
    Kishii, Ryuta
    Takei, Masaya
    Fukuda, Yasumichi
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 609 - 614
  • [30] Structural and functional insights into the T-even type bacteriophage topoisomerase II
    Xin, Yuhui
    Xian, Runqi
    Yang, Yunge
    Cong, Jingyuan
    Rao, Zihe
    Li, Xuemei
    Chen, Yutao
    NATURE COMMUNICATIONS, 2024, 15 (01)